Zydus Animal Health and Investments Limited (ZAHL) a wholly owned material subsidiary of Cadila Healthcare Limited, has entered into a Business Transfer Agreement (BTA) and other Ancillary Agreements (“Definitive Agreements”) to sell and transfer its Animal Healthcare Established Markets Undertaking (“Undertaking” or Zydus AH) to Multiples Alternate Asset Management (“Multiples”) led consortium. Zydus AH is […]
Tag: Pankaj Patel
Zydus Cadila, an innovation-driven global healthcare company, announced that it has signed a non-exclusive licensing agreement with Gilead Sciences Inc., for the manufacturing and distribution of Remdesivir, the investigational drug, which has been issued an Emergency Use Authorization by the U.S. Food and Drug Administration (FDA) to treat patients suffering from severe symptoms of Novel […]